Gilead's remdesivir shows promise in COVID-19 study on monkeys

FILE PHOTO: Two ampules of Ebola drug Remdesivir are pictured during a news conference at the University Hospital Eppendorf in Hamburg, Germany, April 8, 2020, as the spread of coronavirus disease continues. Ulrich Perrey/Pool via REUTERS/File Photo

Remdesivir is the first drug to show improvement in COVID-19 in human trials, and its progress in clinical studies is being closely watched as nations look for a treatment for the disease, which has infected more than 7 million people and killed over 400,000. Macaques that received remdesivir did not show signs of respiratory disease and had reduced damage to the lungs, according to the study.Details from the trial in monkeys were previously released by the U.S. National Institutes of Health in April, but those findings were not reviewed by peers - a step that validates a research study.

Gilead are producing the drug!! Will all the Commander's and their wives be receiving it first Blessed Day....

With the new uptick in Covid_19 cases nation-wide...,going to need this aid to be efective in the fight!!!

Blessed be the fruit

Where’s all the caged children news!?

HCQ shows promise in humans

stock pumping

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

LIVE with HealthyWomen: Mental Wellness & COVID-19'In the media, we talk about black women being 80% overweight or obese but we don’t talk about the underlying causes but we know the role of stress and racially-mediated stress plays,' said lindagblount of blkwomenshealth during our webinar last week.
Source: HealthyWomen - 🏆 29. / 68 Read more »